Repligen Corp’s Sentiment
“Big money sentiment for Repligen Corp (NASDAQ:RGEN) in 2018 Q2 increased to 1.81, SEC.gov filings reveal. So its up 0.42, from 2018Q1’s 1.39. 96 funds opened new and increased holdings, while 53 trimmed and sold stakes in Repligen Corp so the sentiment is more positive. These funds own 38.17 million shares, that’s up from 35.98 million shares in 2018Q1. Funds holding Repligen Corp in top 10 increased from 1 to 2 for an increase of 1. In total 11 funds closed positions, 42 reduced and 71 increased. Also 25 funds bought new Repligen Corp stakes.
Significant Repligen Corp Shareholders
As of 2018 Q2 Ranger Investment Management L.P. has 2.79% invested in Repligen Corp. As of 2018 Q2, 1.71 million shares of Repligen Corp are owned by Conestoga Capital Advisors Llc. Miura Global Management Llc reported 125,000 shares. Redwood Investments Llc revealed 396,088 shares position in Repligen Corp. The Minnesota-based fund Summit Creek Advisors Llc holds 152,677 shares or 1.29% of their portfolio.
Repligen Corporation, a bioprocessing company, focuses on the development, production, and commercialization of products used in the production of antibody therapeutics, recombinant proteins, and vaccines worldwide.The firm is valued at $2.97 billion. It makes various forms of Protein A, a critical component used to purify antibody drugs.The P/E ratio is 130.02. The firm also supplies alternating tangential flow system filtration devices and protein cell culture supplements that are used in clinical and commercial stage manufacturing to enhance biologic drug yields.
RGEN is touching $67.74 during the last trading session, after decreased 1.66%.Repligen Corporation has volume of 428,578 shares. Since November 10, 2017 RGEN has risen 32.84% and is uptrending. RGEN outperformed by 17.22% the S&P500.
Jpmorgan Chase & has invested 0% in Repligen Corporation (NASDAQ:RGEN). 24,253 were reported by Texas Permanent School Fund. California Employees Retirement invested in 0.01% or 105,859 shs. Moreover, Fifth Third National Bank & Trust has 0% invested in Repligen Corporation (NASDAQ:RGEN) for 38 shs. Citadel Advsrs Ltd Liability Company reported 0% stake. Geode Capital Mngmt Ltd Co invested 0.01% of its capital in Repligen Corporation (NASDAQ:RGEN). Miura Global Management Limited Liability Com holds 125,000 shs. National Bank Of Montreal Can, a Ontario – Canada-based fund reported 32,079 shs. Credit Suisse Ag has 0% invested in Repligen Corporation (NASDAQ:RGEN). Eventide Asset Management Ltd Llc owns 0.21% invested in Repligen Corporation (NASDAQ:RGEN) for 110,000 shs. Loomis Sayles And Co Ltd Partnership has 197 shs. Goldman Sachs Group holds 0% or 307,977 shs in its capital. Pnc Fincl Gp has 0% invested in Repligen Corporation (NASDAQ:RGEN) for 58,873 shs. Putnam Investments Ltd Co invested 0% of its capital in Repligen Corporation (NASDAQ:RGEN). Daiwa Secs Gru Inc holds 0% or 241 shs in its capital.
Repligen Corporation had 7 sales and 0 insider purchases since May 11, 2018. This’s net activity of $8.61 million. On Friday, May 11 20,000 shs were sold by DAWES KAREN A, worth $835,936. BARTHELEMY NICOLAS sold $358,196 worth of Repligen Corporation (NASDAQ:RGEN) on Wednesday, August 29. On Monday, September 10 27,566 shs were sold by Hunt Anthony, worth $1.59M. $85,606 worth of stock was sold by RYAN THOMAS F JR on Wednesday, June 6. On Wednesday, May 16 Shares for $5.00 million were sold by EDDLEMAN ROY T.
Repligen Corporation (NASDAQ:RGEN) Ratings Coverage
In total 3 analysts cover Repligen (NASDAQ:RGEN). “Buy” rating has 2, “Sell” are 0, while 1 are “Hold”. (NASDAQ:RGEN) has 67% bullish analysts. 3 are the (NASDAQ:RGEN)’s ratings reports on 10 Nov 2018 according to StockzIntelligence Inc. On Friday, July 20 the company was maintained by Citigroup. On Friday, November 2 JP Morgan maintained the shares of RGEN in report with “Overweight” rating.
For more Repligen Corporation (NASDAQ:RGEN) news posted recently go to: Nasdaq.com, Globenewswire.com, Fool.com, Globenewswire.com or Seekingalpha.com. The titles are as follows: “3 Growth Stocks for In-the-Know Investors” posted on November 04, 2018, “Repligen Reports Third Quarter 2018 Financial Results” on November 01, 2018, “Here’s Why Repligen Rose More Than 16% Today” with a publish date: November 01, 2018, “Repligen to Report Third Quarter 2018 Financial Results” and the last “Repligen Corporation (RGEN) CEO Tony Hunt on Q3 2018 Results – Earnings Call Transcript” with publication date: November 01, 2018.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.